Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

Sergio Prieto-González; Nekane Terrades-García; Marc Corbera-Bellalta; Ester Planas-Rigol; Chie Miyabe; Marco A Alba; Ariel Ponce; Itziar Tavera-Bahillo; Giuseppe Murgia; Georgina Espígol-Frigolé; Javier Marco-Hernández; José Hernández-Rodríguez; Ana García-Martínez; Sebastian H Unizony; Maria C Cid

doi:10.1136/rmdopen-2017-000570

Citation Tools

Vasculitis

Original article

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Prieto-González S, Terrades-García N, Corbera-Bellalta M, et al

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

RMD Open 2017;3:e000570. doi: 10.1136/rmdopen-2017-000570

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password